SAKAR HEALTHCARE LTD : GETS 14 ONCOLOGY PRODUCT APPROVALS IN EU, UK & CANADA

• Sakar Healthcare Ltd. announces progress in strategic initiatives and business momentum. • Company has received 14 oncology product new approvals in the EU (Europe), UK & Canada through 7 business partners. • Approvals cover treatments for various cancer types including breast, lung, prostate, stomach, head & neck, colon & rectum, ovary, liver, kidney, thyroid, blood, bone-marrow and lymph. • Manufacturing site received approval by EMA for 5 product site variations from partner Accord, totaling 6 of 8 technology transfers. • Two partners in the UK and one in Germany received approval for 3 products from MHRA and EMA. • Additionally, 6 licensed-out products received Marketing Authorizations (4 in EU, 1 each in UK and Canada).

Sakar Healthcare Limited

Open attachment

← Back to feed